Antiangiogenic therapy: Tumor suppressor p53 impairs the expression of VEGF and its down stream targets that mediate angiogenesis via up regulation of its target , 28/March/2014, 21.32

Antiangiogenic therapy: Tumor suppressor p53 impairs the expression of VEGF and its down stream targets that mediate angiogenesis via up regulation of its target , 28/March/2014, 21.32

Antiangiogenic therapy: Tumor suppressor p53 impairs the expression of VEGF and its down stream targets that mediate angiogenesis via up regulation of its target , 28/March/2014, 21.32 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Antiangiogenic therapy: Tumor suppressor p53 impairs the expression of VEGF and its down stream targets that mediate angiogenesis via up regulation of its target , 28/March/2014, 21.32,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing